
Krebs Biochemicals & Industries Ltd.
Krebs Biochem.&Inds
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹1.10 Cr.
| EX-Date | Purpose |
|---|---|
| 27 05 2021 | Audited Results |
| 30 07 2021 | Quarterly Results |
| 22 10 2021 | Preferential Issue of shares & Increase in Authorised Capital |
| 09 11 2021 | Quarterly Results |
| 12 02 2022 | Quarterly Results |
| 23 05 2022 | Audited Results |
| 01 08 2022 | Quarterly Results & Inter alia, to consider the following: 1. To consider and approve the un-audited financial results along with the Limited review Report for the quarter ended 30th June, 2022. 2. Any other matter with the permission of the Chair. |
| 10 11 2022 | Quarterly Results |
| 03 02 2023 | Quarterly Results |
| 24 05 2023 | Audited Results |
| 09 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 12 02 2024 | Quarterly Results |
| 11 11 2024 | Quarterly Results |
| 04 02 2025 | Quarterly Results |
| 20 05 2025 | Audited Results |
| 07 08 2025 | Quarterly Results |
| 04 11 2025 | Quarterly Results |
| 09 02 2026 | Quarterly Results |
No News data available
